TY  - GEN
AU  - Paccioni, Niccola
AU  - Rahmani, Mahdieh
AU  - Barcia Hernández, Emilia María
AU  - Negro Álvarez, María Sofía Elisa
PY  - 2022
DO  - 10.3390/pharmaceutics15010013
UR  - https://hdl.handle.net/20.500.14352/125306
T2  - Pharmaceutics
AB  - Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatments...
LA  - eng
M2  - 1 (13)
PB  - MPDI
KW  - Parkinson’s disease
KW  - Polymeric microparticles
KW  - Polymeric nanoparticles
KW  - Neurotrophic factors
KW  - Monoamine oxidase inhibitors
KW  - Antioxidants
KW  - Dopamine agonists
KW  - Catechol-o-methyl transferase inhibitors
KW  - Alpha-synuclein-targeting agents
KW  - Anti-inflammatory agents
TI  - Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
TY  - review article
VL  - 15
ER  -